NIH Awards Karmanos Cancer Institute Breast Cancer Researchers Nearly $3 Million For
 

Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute...

More...